Study of the Structure-Activity Relationship of an Anti-Dormant Mycobacterial Substance 3-(Phenethylamino)Demethyl(oxy)aaptamine to Create a Probe Molecule for Detecting Its Target Protein

The current tuberculosis treatment regimen is long and complex, and its failure leads to relapse and emergence of drug resistance. One of the major reasons underlying the extended chemotherapeutic regimen is the ability of to attain a dormant state. Therefore, the identification of new lead compounds with chemical structures different from those of conventional anti-tuberculosis drugs is essential. The compound 3-(phenethylamino)demethyl(oxy)aaptamine (PDOA, ), isolated from marine sponge of sp., is known as an anti-dormant mycobacterial substance, and has been reported to be effective against the drug resistant strains of . However, its target protein still remains unclear. This study aims to clarify the structure-activity relationship of using 15 synthetic analogues, in order to prepare a probe molecule for detecting the target protein of . We succeeded in creating the compound with a photoaffinity group that retained antimicrobial activity, which proved to be a suitable probe molecule for identifying the target protein of .